SCHEMBL23946327

SCHEMBL23946327

Cc1nc(-c2ccccc2)c2c(-c3ccc4ccccc4c3)cccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.45
ADORA1 P30542 3/20 0.45
PDE10A Q9Y233 1/20 0.42
KCNH2 Q12809 1/20 0.42
AKT1 P31749 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
CYP1A2 P05177 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40
TNNI3 P19429 1/20 0.40
CYP2C19 P33261 1/20 0.40
TNNT2 P45379 1/20 0.40
TNNC1 P63316 1/20 0.40
RUNX1 Q01196 1/20 0.40
CBFB Q13951 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23946343 0.87 KCNH2 (0.44) ADORA1PDE10AKCNH2TDP1KDM4E
SCHEMBL23946292 0.87 KCNH2 (0.49) PDE10AKCNH2AKT1TDP1KDM4E
SCHEMBL23946310 0.87 KCNH2 (0.51) PDE10AKCNH2TDP1KDM4ESMN1; SMN2
SCHEMBL23946340 0.81 KCNH2 (0.46) PDE10AKCNH2TDP1KDM4ESMN1; SMN2
SCHEMBL23946297 0.80 KCNH2 (0.41) ADORA2APDE10AKCNH2TDP1KDM4E
SCHEMBL23946304 0.78 ADORA2A (0.45) ADORA2AADORA1PDE10AAKT1TDP1
SCHEMBL18119038 0.77 ADORA2A (0.49) ADORA2AADORA1PDE10ATDP1KDM4E
SCHEMBL23946336 0.77 PIK3CD (0.48) ADORA2AADORA1PDE10ATDP1KDM4E
SCHEMBL16542821 0.76 ADORA2A (0.47) ADORA2AADORA1PDE10AKDM4ESMN1; SMN2
SCHEMBL29986593 0.76 ADORA2A (0.47) ADORA2AADORA1PDE10AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210328153-A1 ELECTROLUMINESCENT MATERIALS AND DEVICES Beijing Summer Sprout Technology Co., Ltd. (CN) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210328153-A1 ELECTROLUMINESCENT MATERIALS AND DEVICES IDO1, IDO2, AZI2 ADORA2A 333/4885ADORA1 1072/4885PDE10A 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.